Skip to main content
Top
Published in: Rheumatology International 6/2009

01-04-2009 | Case Report

Spondyloepiphyseal dysplasia tarda: four cases from two families

Authors: Serpil Bal, Hikmet Kocyigit, Yasemin Turan, Alev Gurgan, Korhan Baris Bayram, Anıl Güvenc, Zehra Kocaaga, Berna Dirim

Published in: Rheumatology International | Issue 6/2009

Login to get access

Abstract

Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) is an autosomal recessively inherited skeletal dysplasia. We present four patients (three patients—a brother and a sister and their third cousin—in a family and one patient in another family) with SEDT-PA. All patients had short stature and stubby hands and feet. Their radiographs revealed typical changes for SEDT-PA including platyspondyly, severe osteopenia and dysplastic bone changes. Physical therapy and exercises were performed to all patients in order to decrease in pain and increase or at least maintain joint motion and mobility. Symptomatic relief was achieved in all patients for about a couple of months. The major clinical importance of this rather rare disorder is its similarity to juvenile idiopathic arthritis which has rather different treatment protocol.
Literature
1.
go back to reference Wynne-Davies R, Hall C, Ansell BM (1982) Spondylo-epiphyseal dysplasia tarda with progressive arthropathy: a ‘new’ disorder of autosomal recessive inheritance. J Bone Joint Surg 64B:442–445 Wynne-Davies R, Hall C, Ansell BM (1982) Spondylo-epiphyseal dysplasia tarda with progressive arthropathy: a ‘new’ disorder of autosomal recessive inheritance. J Bone Joint Surg 64B:442–445
2.
go back to reference Spranger J, Albert C, Schilling F et al (1983) Progressive pseudorheumatoid arthritis of childhood. A hereditary disorder simulating rheumatoid arthritis. Eur J Pediatr 140:34–40. doi:10.1007/BF00661902 PubMedCrossRef Spranger J, Albert C, Schilling F et al (1983) Progressive pseudorheumatoid arthritis of childhood. A hereditary disorder simulating rheumatoid arthritis. Eur J Pediatr 140:34–40. doi:10.​1007/​BF00661902 PubMedCrossRef
4.
go back to reference El-Shanti HE, Omari HZ, Qubain HI (1997) Progressive pseudorheumatoid dysplasia: report of a family and review. J Med Genet 34:559–563PubMedCrossRef El-Shanti HE, Omari HZ, Qubain HI (1997) Progressive pseudorheumatoid dysplasia: report of a family and review. J Med Genet 34:559–563PubMedCrossRef
5.
go back to reference Spranger J, Albert C, Schilling F (1980) A progressive connective tissue disease with features of juvenile rheumatoid arthritis and osteochondrodysplasia. Eur J Pediatr 133:186–189 Spranger J, Albert C, Schilling F (1980) A progressive connective tissue disease with features of juvenile rheumatoid arthritis and osteochondrodysplasia. Eur J Pediatr 133:186–189
7.
go back to reference Kaptanoglu E, Percin F, Percin S et al (2004) Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Turk J Pediatr 46:380–383PubMed Kaptanoglu E, Percin F, Percin S et al (2004) Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Turk J Pediatr 46:380–383PubMed
13.
go back to reference Tachdjian MO, Wickland EH (1990) Pediatric orthopedics. WB Saunders, Philadelphia, pp 690–749 Tachdjian MO, Wickland EH (1990) Pediatric orthopedics. WB Saunders, Philadelphia, pp 690–749
Metadata
Title
Spondyloepiphyseal dysplasia tarda: four cases from two families
Authors
Serpil Bal
Hikmet Kocyigit
Yasemin Turan
Alev Gurgan
Korhan Baris Bayram
Anıl Güvenc
Zehra Kocaaga
Berna Dirim
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0746-x

Other articles of this Issue 6/2009

Rheumatology International 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.